Pfizer Plans August IPO Filing as Profits Top Estimates

Pfizer Inc., the world’s largest drugmaker, said it will start a filing in mid-August to sell as much as 20 percent of its animal-health unit in an initial public offering. The company also reported profit that beat analysts’ estimates as a result of cost cutting.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.